Common scale minimal sufficient balance: An improved method for covariate-adaptive randomization based on the Wilcoxon-Mann-Whitney odds ratio statistic.
Ontology highlight
ABSTRACT:
SUBMITTER: Johns H
PROVIDER: S-EPMC9303921 | biostudies-literature |
REPOSITORIES: biostudies-literature
Similar Datasets
Project description:We propose an extension of the Wilcoxon-Mann-Whitney test to compare two groups when the outcome variable is latent. We empirically demonstrate that the test can have superior power properties relative to tests based on Structural Equation Modeling for a variety of settings. In addition, several other advantages of the Wilcoxon-Mann-Whitney test are retained such as robustness to outliers and good small sample performance. We demonstrate the proposed methodology on a case study.
| S-EPMC8634887 | biostudies-literature
Project description:For the two-sample problem, the Wilcoxon-Mann-Whitney (WMW) test is used frequently: it is simple to explain (a permutation test on the difference in mean ranks), it handles continuous or ordinal responses, it can be implemented for large or small samples, it is robust to outliers, it requires few assumptions, and it is efficient in many cases. Unfortunately, the WMW test is rarely presented with an effect estimate and confidence interval. A natural effect parameter associated with this test is the Mann-Whitney parameter, ??=?Pr[?X<Y?]?+?0.5 Pr[X?=?Y?]. Ideally, we desire confidence intervals on ? that are compatible with the WMW test, meaning the test rejects at level ? if and only if the 100(1?-??)% confidence interval on the Mann-Whitney parameter excludes 1/2. Existing confidence interval procedures on ? are not compatible with the usual asymptotic implementation of the WMW test that uses a continuity correction nor are they compatible with exact WMW tests. We develop compatible confidence interval procedures for the asymptotic WMW tests and confidence interval procedures for some exact WMW tests that appear to be compatible. We discuss assumptions and interpretation of the resulting tests and confidence intervals. We provide the wmwTest function of the asht R package to calculate all of the developed confidence intervals.
| S-EPMC6377068 | biostudies-literature
Project description:There are many different proposed procedures for sample size planning for the Wilcoxon-Mann-Whitney test at given type-I and type-II error rates α and β, respectively. Most methods assume very specific models or types of data to simplify calculations (eg, ordered categorical or metric data, location shift alternatives, etc). We present a unified approach that covers metric data with and without ties, count data, ordered categorical data, and even dichotomous data. For that, we calculate the unknown theoretical quantities such as the variances under the null and relevant alternative hypothesis by considering the following "synthetic data" approach. We evaluate data whose empirical distribution functions match the theoretical distribution functions involved in the computations of the unknown theoretical quantities. Then, well-known relations for the ranks of the data are used for the calculations. In addition to computing the necessary sample size N for a fixed allocation proportion t = n1 /N, where n1 is the sample size in the first group and N = n1 + n2 is the total sample size, we provide an interval for the optimal allocation rate t, which minimizes the total sample size N. It turns out that, for certain distributions, a balanced design is optimal. We give a characterization of such distributions. Furthermore, we show that the optimal choice of t depends on the ratio of the two variances, which determine the variance of the Wilcoxon-Mann-Whitney statistic under the alternative. This is different from an optimal sample size allocation in case of the normal distribution model.
| S-EPMC6491996 | biostudies-literature
Project description:The Wilcoxon-Mann-Whitney (WMW) test is a popular rank-based two-sample testing procedure for the strong null hypothesis that the two samples come from the same distribution. A modified WMW test, the Fligner-Policello (FP) test, has been proposed for comparing the medians of two populations. A fact that may be underappreciated among some practitioners is that the FP test can also be used to test the strong null like the WMW. In this paper we compare the power of the WMW and FP tests for testing the strong null. Our results show that neither test is uniformly better than the other and that there can be substantial differences in power between the two choices. We propose a new, modified WMW test that combines the WMW and FP tests. Monte Carlo studies show that the combined test has good power compared to either the WMW and FP test. We provide a fast implementation of the proposed test in an open-source software. Supplementary materials are available online.
| S-EPMC6422344 | biostudies-literature
Project description:We consider a two-group randomized clinical trial, where mortality affects the assessment of a follow-up continuous outcome. Using the worst-rank composite endpoint, we develop a weighted Wilcoxon-Mann-Whitney test statistic to analyze the data. We determine the optimal weights for the Wilcoxon-Mann-Whitney test statistic that maximize its power. We derive a formula for its power and demonstrate its accuracy in simulations. Finally, we apply the method to data from an acute ischemic stroke clinical trial of normobaric oxygen therapy.
| S-EPMC5393279 | biostudies-other
Project description:When the distributional assumptions for a t-test are not met, the default position of many analysts is to resort to a rank-based test, such as the Wilcoxon-Mann-Whitney Test to compare the difference in means between two samples. The Wilcoxon-Mann-Whitney Test presents no danger of tied observations when the observations in the data are continuous. However, in practice, observations are discretized due various logical reasons, or the data are ordinal in nature. When ranks are tied, most textbooks recommend using mid-ranks to replace the tied ranks, a practice that affects the distribution of the Wilcoxon-Mann-Whitney Test under the null hypothesis. Other methods for breaking ties have also been proposed. In this study, we examine four tie-breaking methods-average-scores, mid-ranks, jittering, and omission-for their effects on Type I and Type II error of the Wilcoxon-Mann-Whitney Test and the two-sample t-test for various combinations of sample sizes, underlying population distributions, and percentages of tied observations. We use the results to determine the maximum percentage of ties for which the power and size are seriously affected, and for which method of tie-breaking results in the best Type I and Type II error properties. Not surprisingly, the underlying population distribution of the data has less of an effect on the Wilcoxon-Mann-Whitney Test than on the t-test. Surprisingly, we find that the jittering and omission methods tend to hold Type I error at the nominal level, even for small sample sizes, with no substantial sacrifice in terms of Type II error. Furthermore, the t-test and the Wilcoxon-Mann-Whitney Test are equally effected by ties in terms of Type I and Type II error; therefore, we recommend omitting tied observations when they occur for both the two-sample t-test and the Wilcoxon-Mann-Whitney due to the bias in Type I error that is created when tied observations are left in the data, in the case of the t-test, or adjusted using mid-ranks or average-scores, in the case of the Wilcoxon-Mann-Whitney.
| S-EPMC6057651 | biostudies-literature
Project description:We consider a clinical trial of a potentially lethal disease in which patients are randomly assigned to two treatment groups and are followed for a fixed period of time; a continuous endpoint is measured at the end of follow-up. For some patients; however, death (or severe disease progression) may preclude measurement of the endpoint. A statistical analysis that includes only patients with endpoint measurements may be biased. An alternative analysis includes all randomized patients, with rank scores assigned to the patients who are available for the endpoint measurement on the basis of the magnitude of their responses and with 'worst-rank' scores assigned to those patients whose death precluded the measurement of the continuous endpoint. The worst-rank scores are worse than all observed rank scores. The treatment effect is then evaluated using the Wilcoxon-Mann-Whitney test. In this paper, we derive closed-form formulae for the power and sample size of the Wilcoxon-Mann-Whitney test when missing measurements of the continuous endpoints because of death are replaced by worst-rank scores. We distinguish two approaches for assigning the worst-rank scores. In the tied worst-rank approach, all deaths are weighted equally, and the worst-rank scores are set to a single value that is worse than all measured responses. In the untied worst-rank approach, the worst-rank scores further rank patients according to their time of death, so that an earlier death is considered worse than a later death, which in turn is worse than all measured responses. In addition, we propose four methods for the implementation of the sample size formulae for a trial with expected early death. We conduct Monte Carlo simulation studies to evaluate the accuracy of our power and sample size formulae and to compare the four sample size estimation methods.
| S-EPMC4289456 | biostudies-other
Project description:We describe the implementation of minimal sufficient balance randomization, a covariate-adaptive randomization technique, used for the "Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times" (ESCAPE) trial.The ESCAPE trial is a prospective, multicenter, randomized clinical trial that enrolled subjects with the following main inclusion criteria: less than 12 h from symptom onset, age 18 years or older, baseline NIHSS score?>?5, ASPECTS score?>?5 and computed tomography angiography (CTA) evidence of carotid T/L or M1-segment middle cerebral artery (MCA) occlusion, and at least moderate collaterals by CTA. Patients were randomized using a real-time, dynamic, Internet-based, minimal sufficient balance randomization method that balanced the study arms with respect to baseline covariates including age, sex, baseline NIHSS score, site of arterial occlusion, baseline ASPECTS score and treatment with intravenously administered alteplase.Permutation-based tests of group differences confirmed group balance across several baseline covariates including sex (p?=?1.00), baseline NIHSS score (p?=?0.95), site of arterial occlusion (p?=?1.00), baseline ASPECTS score (p?=?0.28), treatment with intravenously administered alteplase (p?=?0.31), and age (p?=?0.67).Results from the ESCAPE trial demonstrate the feasibility and the benefit of this covariate adaptive randomization scheme in small-sample trials and for data monitoring endeavors.ESCAPE trial - NCT01778335 - at www.clinicaltrials.gov . Registered on 29 January 2013.
| S-EPMC5667454 | biostudies-literature
Project description:Although comorbidity among complex diseases (e.g., drug dependence syndromes) is well documented, genetic variants contributing to the comorbidity are still largely unknown. The discovery of genetic variants and their interactions contributing to comorbidity will likely shed light on underlying pathophysiological and etiological processes, and promote effective treatments for comorbid conditions. For this reason, studies to discover genetic variants that foster the development of comorbidity represent high-priority research projects, as manifested in the behavioral genetics studies now underway. The yield from these studies can be enhanced by adopting novel statistical approaches, with the capacity of considering multiple genetic variants and possible interactions. For this purpose, we propose a bivariate Mann-Whitney (BMW) approach to unravel genetic variants and interactions contributing to comorbidity, as well as those unique to each comorbid condition. Through simulations, we found BMW outperformed two commonly adopted approaches in a variety of underlying disease and comorbidity models. We further applied BMW to datasets from the Study of Addiction: Genetics and Environment, investigating the contribution of 184 known nicotine dependence (ND) and alcohol dependence (AD) single nucleotide polymorphisms (SNPs) to the comorbidity of ND and AD. The analysis revealed a candidate SNP from CHRNA5, rs16969968, associated with both ND and AD, and replicated the findings in an independent dataset with a P-value of 1.06 × 10(-03) .
| S-EPMC3760410 | biostudies-literature
Project description:Common complex diseases are likely influenced by the interplay of hundreds, or even thousands, of genetic variants. Converging evidence shows that genetic variants with low marginal effects (LMEs) play an important role in disease development. Despite their potential significance, discovering LME genetic variants and assessing their joint association on high-dimensional data (e.g., genome-wide data) remain a great challenge. To facilitate joint association analysis among a large ensemble of LME genetic variants, we proposed a computationally efficient and powerful approach, which we call Trees Assembling Mann-Whitney (TAMW). Through simulation studies and an empirical data application, we found that TAMW outperformed multifactor dimensionality reduction (MDR) and the likelihood ratio-based Mann-Whitney approach (LRMW) when the underlying complex disease involves multiple LME loci and their interactions. For instance, in a simulation with 20 interacting LME loci, TAMW attained a higher power (power = 0.931) than both MDR (power = 0.599) and LRMW (power = 0.704). In an empirical study of 29 known Crohn's disease (CD) loci, TAMW also identified a stronger joint association with CD than those detected by MDR and LRMW. Finally, we applied TAMW to Wellcome Trust CD GWAS to conduct a genome-wide analysis. The analysis of 459K single nucleotide polymorphisms was completed in 40 hrs using parallel computing, and revealed a joint association predisposing to CD (P-value = 2.763 × 10(-19)). Further analysis of the newly discovered association suggested that 13 genes, such as ATG16L1 and LACC1, may play an important role in CD pathophysiological and etiological processes.
| S-EPMC3593719 | biostudies-literature